Open for inclusion

A phase II trial of ibrutinib, lenalidomide and rituximab for patients with relapsed/refractory mantle cell lymphoma

Cancer type: Lymphoma

Phase: II

Principal Investigator: Bentzen Hans

Country: DK

Keywords: Denmark, Aarhus

Status: Inclusion completed

Link to Clinicaltrials.gov: EudraCT no. 2013-005541-36